Enhanced phagocytosis in OCI-Ly3 cells is achieved when BMS-986351 is combined with rituximab.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: